SCHEMBL29633788

SCHEMBL29633788

CN(C(=O)OCC1c2ccccc2-c2ccccc21)C(CCc1ccccc1F)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FABP5 Q01469 3/20 0.38
FABP7 O15540 2/20 0.38
KMT2A Q03164 4/20 0.37
PPIA P62937 2/20 0.37
MEN1 O00255 2/20 0.37
ATM Q13315 1/20 0.37
EPHX2 P34913 1/20 0.36
CASP3 P42574 1/20 0.36
MDM2 Q00987 2/20 0.35
MDM4 O15151 1/20 0.35
TP53 P04637 1/20 0.35
GAA P10253 1/20 0.35
NPC1 O15118 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
HTT P42858 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31370296 1.00 FABP5 (0.38) FABP5FABP7KMT2APPIAMEN1
SCHEMBL31688572 0.94 KMT2A (0.37) FABP5FABP7KMT2APPIAMEN1
SCHEMBL25354436 0.90 FABP5 (0.39) FABP5FABP7KMT2AMEN1ATM
SCHEMBL25354435 0.90 FABP5 (0.39) FABP5FABP7KMT2AMEN1ATM
SCHEMBL25182263 0.89 FABP5 (0.39) FABP5FABP7KMT2APPIAMEN1
SCHEMBL29855060 0.89 FABP5 (0.39) FABP5FABP7KMT2APPIAMEN1
SCHEMBL30792882 0.89 FABP5 (0.39) FABP5FABP7KMT2APPIAMEN1
SCHEMBL25182264 0.89 FABP5 (0.39) FABP5FABP7KMT2APPIAMEN1
SCHEMBL6318272 0.89 FABP5 (0.39) FABP5FABP7KMT2APPIAMEN1
SCHEMBL31688515 0.88 FABP5 (0.38) FABP5FABP7KMT2AMEN1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240376044-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE CHUGAI PHARMACEUTICAL CO LTD (JP) 2024-11-14 US disclosed
US-12071396-B2 Method for preparing aromatic amino acid derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-08-27 US disclosed
US-20220144762-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2022-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240376044-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE DDC, AADAT, TYR FABP5 608/4885FABP7 1148/4885KMT2A 355/4885
US-20220144762-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE DDC, AADAT, TYR FABP5 608/4885FABP7 1148/4885KMT2A 355/4885
US-12071396-B2 Method for preparing aromatic amino acid derivative DDC, AADAT, TYR FABP5 608/4885FABP7 1148/4885KMT2A 355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.